Anthony D. Ormerod

8.2k total citations
99 papers, 4.3k citations indexed

About

Anthony D. Ormerod is a scholar working on Dermatology, Immunology and Epidemiology. According to data from OpenAlex, Anthony D. Ormerod has authored 99 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Dermatology, 27 papers in Immunology and 21 papers in Epidemiology. Recurrent topics in Anthony D. Ormerod's work include Dermatology and Skin Diseases (22 papers), Contact Dermatitis and Allergies (17 papers) and Psoriasis: Treatment and Pathogenesis (17 papers). Anthony D. Ormerod is often cited by papers focused on Dermatology and Skin Diseases (22 papers), Contact Dermatitis and Allergies (17 papers) and Psoriasis: Treatment and Pathogenesis (17 papers). Anthony D. Ormerod collaborates with scholars based in United Kingdom, Australia and United States. Anthony D. Ormerod's co-authors include Catherine Smith, Nick J. Reynolds, Richard Weller, A. David Burden, C.E.M. Griffiths, Juliet N. Barker, Nigel Benjamin, A.V. Anstey, David J. Gawkrodger and Richard B. Warren and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Cochrane Database of Systematic Reviews.

In The Last Decade

Anthony D. Ormerod

96 papers receiving 4.1k citations

Peers

Countries citing papers authored by Anthony D. Ormerod

Since Specialization

Citations

This map shows the geographic impact of Anthony D. Ormerod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony D. Ormerod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony D. Ormerod more than expected).

Fields of papers citing papers by Anthony D. Ormerod

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony D. Ormerod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony D. Ormerod. The network helps show where Anthony D. Ormerod may publish in the future.

Co-authorship network of co-authors of Anthony D. Ormerod

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony D. Ormerod. A scholar is included among the top collaborators of Anthony D. Ormerod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony D. Ormerod. Anthony D. Ormerod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non‐biologic systemic therapies 2021 ·Journal of the European Academy of Dermatology and Venereology ·K.J. Mason, A. David Burden, Juliet N. Barker, Mark Lunt, (unknown), C. Elise Kleyn, Kathleen McElhone, Moetaza M. Soliman, Adèle C. Green, C.E.M. Griffiths, Nick J. Reynolds, Anthony D. Ormerod, (unknown)	3
2	Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR 2021 ·Journal of the European Academy of Dermatology and Venereology ·K.J. Mason, A. David Burden, Juliet N. Barker, Mark Lunt, (unknown), C. Elise Kleyn, Kathleen McElhone, Moetaza M. Soliman, Adèle C. Green, C.E.M. Griffiths, Nick J. Reynolds, Anthony D. Ormerod, (unknown)	4
3	Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register ( BADBIR ) 2018 ·British Journal of Dermatology ·Zenas Z N Yiu, Darren M. Ashcroft, Ian Evans, Kathleen McElhone, Mark Lunt, Catherine Smith, Shernaz Walton, Ruth Murphy, Nick J. Reynolds, Anthony D. Ormerod, C.E.M. Griffiths, Richard B. Warren, (unknown)	26
4	Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR) 2017 ·Journal of Investigative Dermatology ·Zenas Z N Yiu, Catherine Smith, Darren M. Ashcroft, Mark Lunt, Shernaz Walton, Ruth Murphy, Nick J. Reynolds, Anthony D. Ormerod, C.E.M. Griffiths, Richard B. Warren	49
5	Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR) 2015 ·Journal of Investigative Dermatology ·Richard B. Warren, Catherine Smith, Zenas Z N Yiu, Darren M. Ashcroft, Juliet N. Barker, A. David Burden, Mark Lunt, Kathleen McElhone, Anthony D. Ormerod, Caroline Owen, Nick J. Reynolds, C.E.M. Griffiths	276
6	Treatment of Acne in Children 2014 ·American Journal of Clinical Dermatology ·(unknown), Anthony D. Ormerod	3
7	Influence of isotretinoin on hippocampal-based learning in human subjects 2011 ·Psychopharmacology ·Anthony D. Ormerod, (unknown), (unknown), Ian Reid, Justin H. G. Williams, Peter McCaffery	32
8	Guideline for the diagnosis and management of vitiligo 2008 ·British Journal of Dermatology ·David J. Gawkrodger, Anthony D. Ormerod, Lindsay Shaw, (unknown), Maxine E Whitton, MJ Watts, A.V. Anstey, J. Ingham, (unknown)	225
9	The British standard series of contact dermatitis allergens: validation in clinical practice and value for clinical governance 2003 ·British Journal of Dermatology ·Jason Britton, Mark Wilkinson, John English, David J. Gawkrodger, Anthony D. Ormerod, Jane Sansom, S. Shaw, B. N. Statham	57
10	Dermatitis herpetiformis effectively treated with heparin, tetracycline and nicotinamide 2000 ·Clinical and Experimental Dermatology ·(unknown), Anthony D. Ormerod	23
11	The Inflammatory and Cytotoxic Effects of a Nitric Oxide Releasing Cream on Normal Skin 1999 ·Journal of Investigative Dermatology ·Anthony D. Ormerod, Paul M. Copeland, (unknown), Akhtar Husain, Stanley W. B. Ewen	60
12	DEPARTMENT OF ERROR 1997 ·The Lancet ·Nigel Benjamin, (unknown), Richard Weller, Lorna Smith, Anthony D. Ormerod, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
13	Discoid lupus erythematosus in an X-linked cytochrome-positive carrier of chronic granulomatous disease 1992 ·British Journal of Dermatology ·Grant R. Yeaman, Karin S. Froebel, George Galea, Anthony D. Ormerod, S. J. Urbaniak	17
14	Calcium Antagonist in the Treatment of Symptomatic Dermographism 1988 ·Dermatology ·Frances Lawlor, Anthony D. Ormerod, M. Greaves	16
15	Terfenadine and Brompheniramine Maleate in Urticaria and Dermographism 1986 ·Dermatology ·Anthony D. Ormerod, Roger Baker, (unknown), (unknown)	9
16	The Wiskott‐Aldrich Syndrome 1985 ·International Journal of Dermatology ·Anthony D. Ormerod	1
17	The Wiskott‐Aldrich Syndrome 1985 ·International Journal of Dermatology ·Anthony D. Ormerod	3
18	Syncope. 1984 ·BMJ ·Anthony D. Ormerod	3
19	Urticaria and angio-oedema. 1984 ·BMJ ·Anthony D. Ormerod	5
20	Dermatitis. 1984 ·BMJ ·Anthony D. Ormerod, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact